Copyright Reports & Markets. All rights reserved.

Global Blood Plasma Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Blood Plasma Market Overview

      • 1.1 Product Overview and Scope of Blood Plasma
      • 1.2 Blood Plasma Segment by Type
        • 1.2.1 Global Blood Plasma Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Immunoglobulin
        • 1.2.3 Albumin
        • 1.2.4 Protease Inhibitors
        • 1.2.5 Coagulation Factor Concentrates
        • 1.2.6 Others
      • 1.3 Blood Plasma Segment by Application
        • 1.3.1 Blood Plasma Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals and Clinics
        • 1.3.3 Research Laboratories
        • 1.3.4 Academic Institutions
      • 1.4 Global Blood Plasma Market by Region
        • 1.4.1 Global Blood Plasma Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Blood Plasma Market Size
        • 1.5.1 Global Blood Plasma Revenue (2014-2025)
        • 1.5.2 Global Blood Plasma Production (2014-2025)

      2 Global Blood Plasma Market Competition by Manufacturers

      • 2.1 Global Blood Plasma Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Blood Plasma Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Blood Plasma Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Blood Plasma Production Sites, Area Served, Product Types
      • 2.5 Blood Plasma Market Competitive Situation and Trends
        • 2.5.1 Blood Plasma Market Concentration Rate
        • 2.5.2 Blood Plasma Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Blood Plasma Production Market Share by Regions

      • 3.1 Global Blood Plasma Production Market Share by Regions
      • 3.2 Global Blood Plasma Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Blood Plasma Production
        • 3.4.1 North America Blood Plasma Production Growth Rate (2014-2019)
        • 3.4.2 North America Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Blood Plasma Production
        • 3.5.1 Europe Blood Plasma Production Growth Rate (2014-2019)
        • 3.5.2 Europe Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Blood Plasma Production (2014-2019)
        • 3.6.1 China Blood Plasma Production Growth Rate (2014-2019)
        • 3.6.2 China Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Blood Plasma Production (2014-2019)
        • 3.7.1 Japan Blood Plasma Production Growth Rate (2014-2019)
        • 3.7.2 Japan Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Blood Plasma Consumption by Regions

      • 4.1 Global Blood Plasma Consumption by Regions
      • 4.2 North America Blood Plasma Consumption (2014-2019)
      • 4.3 Europe Blood Plasma Consumption (2014-2019)
      • 4.4 China Blood Plasma Consumption (2014-2019)
      • 4.5 Japan Blood Plasma Consumption (2014-2019)

      5 Global Blood Plasma Production, Revenue, Price Trend by Type

      • 5.1 Global Blood Plasma Production Market Share by Type (2014-2019)
      • 5.2 Global Blood Plasma Revenue Market Share by Type (2014-2019)
      • 5.3 Global Blood Plasma Price by Type (2014-2019)
      • 5.4 Global Blood Plasma Production Growth by Type (2014-2019)

      6 Global Blood Plasma Market Analysis by Applications

      • 6.1 Global Blood Plasma Consumption Market Share by Application (2014-2019)
      • 6.2 Global Blood Plasma Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Blood Plasma Business

      • 7.1 Baxter International
        • 7.1.1 Baxter International Blood Plasma Production Sites and Area Served
        • 7.1.2 Blood Plasma Product Introduction, Application and Specification
        • 7.1.3 Baxter International Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 CSL
        • 7.2.1 CSL Blood Plasma Production Sites and Area Served
        • 7.2.2 Blood Plasma Product Introduction, Application and Specification
        • 7.2.3 CSL Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Grifols
        • 7.3.1 Grifols Blood Plasma Production Sites and Area Served
        • 7.3.2 Blood Plasma Product Introduction, Application and Specification
        • 7.3.3 Grifols Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Octapharma
        • 7.4.1 Octapharma Blood Plasma Production Sites and Area Served
        • 7.4.2 Blood Plasma Product Introduction, Application and Specification
        • 7.4.3 Octapharma Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 ADMA Biologics
        • 7.5.1 ADMA Biologics Blood Plasma Production Sites and Area Served
        • 7.5.2 Blood Plasma Product Introduction, Application and Specification
        • 7.5.3 ADMA Biologics Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Cerus Corp
        • 7.6.1 Cerus Corp Blood Plasma Production Sites and Area Served
        • 7.6.2 Blood Plasma Product Introduction, Application and Specification
        • 7.6.3 Cerus Corp Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanquin
        • 7.7.1 Sanquin Blood Plasma Production Sites and Area Served
        • 7.7.2 Blood Plasma Product Introduction, Application and Specification
        • 7.7.3 Sanquin Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Shanghai Raas
        • 7.8.1 Shanghai Raas Blood Plasma Production Sites and Area Served
        • 7.8.2 Blood Plasma Product Introduction, Application and Specification
        • 7.8.3 Shanghai Raas Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 TCS Biosciences
        • 7.9.1 TCS Biosciences Blood Plasma Production Sites and Area Served
        • 7.9.2 Blood Plasma Product Introduction, Application and Specification
        • 7.9.3 TCS Biosciences Blood Plasma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Blood Plasma Manufacturing Cost Analysis

      • 8.1 Blood Plasma Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Blood Plasma
      • 8.4 Blood Plasma Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Blood Plasma Distributors List
      • 9.3 Blood Plasma Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Blood Plasma Market Forecast

      • 11.1 Global Blood Plasma Production, Revenue Forecast
        • 11.1.1 Global Blood Plasma Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Blood Plasma Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Blood Plasma Price and Trend Forecast (2019-2025)
      • 11.2 Global Blood Plasma Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Blood Plasma Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Blood Plasma Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Blood Plasma Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Blood Plasma Production, Revenue Forecast (2019-2025)
      • 11.3 Global Blood Plasma Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Blood Plasma Consumption Forecast (2019-2025)
        • 11.3.2 Europe Blood Plasma Consumption Forecast (2019-2025)
        • 11.3.3 China Blood Plasma Consumption Forecast (2019-2025)
        • 11.3.4 Japan Blood Plasma Consumption Forecast (2019-2025)
      • 11.4 Global Blood Plasma Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Blood Plasma Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Plasma is the liquid portion of the blood. Plasma is the versatile component and makes about 55% of the blood. Plasma is the composite mixture of more than 700 proteins and other substances which are vital for the efficient functioning of the human body. Plasma helps in regulating body temperature and blood pressure. It serves as a medium for exchange of proteins, nutrients and hormones to the different parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma. Plasma is extracted as proteins and substances and used as main ingredients in medical products to replace body fluids, clotting factors and antibodies. Plasma is used as a component for the treatment of serious health problems such as hemophilia and autoimmune disorders.
        North America dominates the global market for blood plasma due to large number of aging population. Asia followed by the Europe is expected to show high growth rates in the next five years in global blood plasma market. China is expected to be the fastest growing blood plasma markets in Asia region. Some of the key driving forces for blood plasma market in emerging countries are large pool of patients and rising government funding. 

        The global Blood Plasma market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Blood Plasma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Plasma market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Baxter International
        CSL
        Grifols
        Octapharma
        ADMA Biologics
        Cerus Corp
        Sanquin
        Shanghai Raas
        TCS Biosciences

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Immunoglobulin
        Albumin
        Protease Inhibitors
        Coagulation Factor Concentrates
        Others

        Segment by Application
        Hospitals and Clinics
        Research Laboratories
        Academic Institutions

        Buy now